United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jan. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
331 Sigilon Therapeutics, Inc. $53.3 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
332 Ovid Therapeutics Inc. $52.1 M United States US Healthcare US Biotechnology
333 FibroGen, Inc. $51.0 M United States US Healthcare US Biotechnology
334 Reneo Pharmaceuticals, Inc. $50.7 M

(July 1, 2024)

 United States US Healthcare US Biotechnology
335 Fortress Biotech, Inc. $50.2 M United States US Healthcare US Biotechnology
336 Outlook Therapeutics, Inc. $49.6 M United States US Healthcare US Biotechnology
337 Aeglea BioTherapeutics, Inc. $48.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
338 Atara Biotherapeutics, Inc. $47.3 M United States US Healthcare US Biotechnology
339 Spero Therapeutics, Inc. $47.3 M United States US Healthcare US Biotechnology
340 Passage Bio, Inc. $46.9 M United States US Healthcare US Biotechnology
341 AlloVir, Inc. $46.6 M United States US Healthcare US Biotechnology
342 Kezar Life Sciences, Inc. $46.3 M United States US Healthcare US Biotechnology
343 Aileron Therapeutics, Inc. $45.7 M United States US Healthcare US Biotechnology
344 Dyadic International, Inc. $45.6 M United States US Healthcare US Biotechnology
345 Actinium Pharmaceuticals, Inc. $41.8 M United States US Healthcare US Biotechnology
346 Lantern Pharma Inc. $41.3 M United States US Healthcare US Biotechnology
347 CASI Pharmaceuticals, Inc. $41.2 M United States US Healthcare US Biotechnology
348 VYNE Therapeutics Inc. $40.7 M United States US Healthcare US Biotechnology
349 AzurRx BioPharma, Inc. $39.3 M United States US Healthcare US Biotechnology
350 BioVie Inc. $34.3 M United States US Healthcare US Biotechnology
351 Ocuphire Pharma, Inc. $31.7 M United States US Healthcare US Biotechnology
352 CEL-SCI Corporation $30.8 M United States US Healthcare US Biotechnology
353 Angion Biomedica Corp $30.1 M

(June 1, 2023)

 United States US Healthcare US Biotechnology
354 Marinus Pharmaceuticals, Inc. $29.9 M United States US Healthcare US Biotechnology
355 Longeveron, Inc. $29.1 M United States US Healthcare US Biotechnology
356 Curis, Inc. $29.0 M United States US Healthcare US Biotechnology
357 BioAtla, Inc. $28.5 M United States US Healthcare US Biotechnology
358 Citius Pharmaceuticals, Inc. $28.0 M United States US Healthcare US Biotechnology
359 Cara Therapeutics, Inc. $27.4 M United States US Healthcare US Biotechnology
360 Cyclo Therapeutics, Inc. $26.9 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jan. 01, 2025

331. Sigilon Therapeutics, Inc.

Company Profile: Sigilon Therapeutics, Inc.
Market Cap (USD): $53.3 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

332. Ovid Therapeutics Inc.

Company Profile: Ovid Therapeutics Inc.
Market Cap (USD): $52.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

333. FibroGen, Inc.

Company Profile: FibroGen, Inc.
Market Cap (USD): $51.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

334. Reneo Pharmaceuticals, Inc.

Company Profile: Reneo Pharmaceuticals, Inc.
Market Cap (USD): $50.7 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

335. Fortress Biotech, Inc.

Company Profile: Fortress Biotech, Inc.
Market Cap (USD): $50.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

336. Outlook Therapeutics, Inc.

Company Profile: Outlook Therapeutics, Inc.
Market Cap (USD): $49.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

337. Aeglea BioTherapeutics, Inc.

Company Profile: Aeglea BioTherapeutics, Inc.
Market Cap (USD): $48.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

338. Atara Biotherapeutics, Inc.

Company Profile: Atara Biotherapeutics, Inc.
Market Cap (USD): $47.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

339. Spero Therapeutics, Inc.

Company Profile: Spero Therapeutics, Inc.
Market Cap (USD): $47.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

340. Passage Bio, Inc.

Company Profile: Passage Bio, Inc.
Market Cap (USD): $46.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

341. AlloVir, Inc.

Company Profile: AlloVir, Inc.
Market Cap (USD): $46.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

342. Kezar Life Sciences, Inc.

Company Profile: Kezar Life Sciences, Inc.
Market Cap (USD): $46.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

343. Aileron Therapeutics, Inc.

Company Profile: Aileron Therapeutics, Inc.
Market Cap (USD): $45.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

344. Dyadic International, Inc.

Company Profile: Dyadic International, Inc.
Market Cap (USD): $45.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

345. Actinium Pharmaceuticals, Inc.

Company Profile: Actinium Pharmaceuticals, Inc.
Market Cap (USD): $41.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

346. Lantern Pharma Inc.

Company Profile: Lantern Pharma Inc.
Market Cap (USD): $41.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

347. CASI Pharmaceuticals, Inc.

Company Profile: CASI Pharmaceuticals, Inc.
Market Cap (USD): $41.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

348. VYNE Therapeutics Inc.

Company Profile: VYNE Therapeutics Inc.
Market Cap (USD): $40.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

349. AzurRx BioPharma, Inc.

Company Profile: AzurRx BioPharma, Inc.
Market Cap (USD): $39.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

350. BioVie Inc.

Company Profile: BioVie Inc.
Market Cap (USD): $34.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

351. Ocuphire Pharma, Inc.

Company Profile: Ocuphire Pharma, Inc.
Market Cap (USD): $31.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

352. CEL-SCI Corporation

Company Profile: CEL-SCI Corporation
Market Cap (USD): $30.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

353. Angion Biomedica Corp

Company Profile: Angion Biomedica Corp
Market Cap (USD): $30.1 M (June 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

354. Marinus Pharmaceuticals, Inc.

Company Profile: Marinus Pharmaceuticals, Inc.
Market Cap (USD): $29.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

355. Longeveron, Inc.

Company Profile: Longeveron, Inc.
Market Cap (USD): $29.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

356. Curis, Inc.

Company Profile: Curis, Inc.
Market Cap (USD): $29.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

357. BioAtla, Inc.

Company Profile: BioAtla, Inc.
Market Cap (USD): $28.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

358. Citius Pharmaceuticals, Inc.

Company Profile: Citius Pharmaceuticals, Inc.
Market Cap (USD): $28.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

359. Cara Therapeutics, Inc.

Company Profile: Cara Therapeutics, Inc.
Market Cap (USD): $27.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

360. Cyclo Therapeutics, Inc.

Company Profile: Cyclo Therapeutics, Inc.
Market Cap (USD): $26.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch